Employers & Consultants

Line Art 1
Line Art 2
Line Art 3
Line Art 4

Prescryptive Health’s PBM Savings Verified by the Validation Institute

The company’s transparent pharmacy benefit solution delivers improved total prescription costs in third-party report.

As Seen In: HIT Consultant

Prescryptive Health Taps Lilly on First-to-Market Value-Based Program to Stabilize Insulin Pricing

Prescryptive Health partnered with Eli Lilly and Company on a new subscription model to help lower costs for…

4 demands to make in your next PBM contract

Pharmacy benefits contracts are complicated. But plan sponsors have the power to control the contract conversation. Here's how.

As Seen In: Formulary Watch

Prescryptive Health Partners with Lilly for Insulin Program

Prescryptive Health has partnered with Eli Lilly to create a subscription-based insulin program for employers that aims to…

Prescryptive Health Partners with Lilly on First-to-Market Value-Based Program to Stabilize Insulin Pricing

The new financial model aims to provide price transparency while encouraging medication adherence.

Pharmacy benefits: 3 questions to ask to reduce plan costs

Asking these three questions about your pharmacy benefits plan can lead to bigger savings and a better member…

As Seen In: Healthcare Americana

PODCAST: Prescryptive’s Chris Blackley on Prescription Drug Market Transparency

Prescryptive CEO, Chris Blackley, joins the Healthcare Americana podcast to discuss the root of the prescription drug pricing…

Transcarent Selects Prescryptive Health to Power a New, Different and Better Integrated Pharmacy Experience

Partnership will offer a comprehensive and transparent experience for Transcarent Members.

As Seen In: BenefitsPRO

IRA means increased drug prices for commercial plans: Ways to prepare

Drug prices for commercial health plans could increase under the recently passed Inflation Reduction Act. HR must act…

As Seen In: MedCity News

Pharmacy benefit managers inflate drug prices and decrease competition while consumers pay the price. Does the FTC have the medicine to fix it?

Our CEO Chris Blackley writes in MedCity News about the FTC’s new probe into the big pharmacy benefit…

As Seen In: Forbes

Drug Price Transparency Stymies Consumers, New Survey Shows

As Deb Gordon writes in Forbes about our Pharmacy Trends survey, “…90% of survey respondents said they would appreciate…

As Seen In: BenefitsPRO

3 reasons why owning your pharmacy benefits data matters

Owning your pharmacy benefits data is a must. In her latest Benefits PRO article, Andrea Pickett, Prescryptive’s Chief…